Please assess the completion status of the following clinical trial:

Trial Title: Intraoperative Imaging of Pituitary Adenomas by OTL

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Adult patients over 18 years of age~2. Patients presenting with a pituitary nodule presumed to be resectable on pre-operative assessment~3. Good operative candidate~4. Subject capable of giving informed consent and participating in the process of consent.~Exclusion Criteria:~1. Pregnant women as determined by urinary or serum beta human chorionic gonadotropin (hCG) within 72 hours of surgery~2. Patients with a history of anaphylactic reactions to OTL38~3. Patients with a known allergy to Benadryl~4. Previous exposure to OTL38

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- OTL38 (Type: EXPERIMENTAL): Dosage calculated by weight of individual

Based on this trial design, predict the completion outcome and termination type (if applicable).